Improving immunization coverage and equity - technical resources
Comparing Resources
Tip: You can share the address of this page to allow others to view your comparison
| Resource | UNIVAC |
|---|---|
| Purpose | Universal vaccine impact and cost-effectiveness decision support model. Relevant to Haemophilus Influenzae, pneumococcal disease, rotavirus, human papillomavirus and meningococcal disease. |
| Content | UNIVAC is a single universal vaccine impact and cost-effectiveness decision support model with a standardized, accessible Excel-based (now based in R), interface and a familiar set of input steps and outputs. Input estimates of age-specific disease burden, age/dose specific vaccine coverage and effectiveness allow for a simple evaluation of direct vaccination impact on health outcomes. Additional input parameters can be included to evaluate indirect effects, which may be important for the evaluation of several vaccines. The tool features automated calculations, options for sensitivity analysis and automatically generated results charts and figures. The primary audience is national multi-disciplinary teams of Ministries of Health personnel. Secondary audiences are national, regional and international academics, donors and partner institutions. |
| Use | Requires user input. It is a modeling tool, and thus the user needs to select what data will use and also set the assumptions. |
| Contraints/Limitations | • Now based in R and thus requires basic knowledge of R. •The quality of the model will depend on the data used and the assumptions made by the user. |
| Example criteria this resource could address | Estimation of the direct and indirect impact of vaccination on health outcomes. |
| If available, notes on the development process | Part of the PAHO's Provac e-Toolkit. It has been reviewed during an expert review, where participants represented a wide range of institutions UNICEF, PATH, Sabin Vaccine Institute, CDC, Bill and Melinda Gates Foundation, Argentina’s Ministry of Health, Instituto de Efectividad Clínica y Sanitaria, INSP/Universidad Nacional de Colombia, London School of Hygiene and Tropical Medicine, University of Washington, University of North Carolina, Rutgers, Universidad de Cartagena. The ProVac toolkit, which UNIVAC is part of has supported 43 country-level vaccine cost-effectiveness analysis. |
| Additional Links | |
| Link to access the resource | /en/resources/tool/univac |